These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15230078)

  • 1. Neurological and developmental outcomes of prenatally cocaine-exposed offspring from 12 to 36 months.
    Lewis MW; Misra S; Johnson HL; Rosen TS
    Am J Drug Alcohol Abuse; 2004 May; 30(2):299-320. PubMed ID: 15230078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of prenatal cocaine exposure and scores on the Bayley Scales of Infant Development: modifying effects of caregiver, early intervention, and birth weight.
    Frank DA; Jacobs RR; Beeghly M; Augustyn M; Bellinger D; Cabral H; Heeren T
    Pediatrics; 2002 Dec; 110(6):1143-52. PubMed ID: 12456912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and motor outcomes of cocaine-exposed infants.
    Singer LT; Arendt R; Minnes S; Farkas K; Salvator A; Kirchner HL; Kliegman R
    JAMA; 2002 Apr; 287(15):1952-60. PubMed ID: 11960537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The developmental implications of prenatal and/or postnatal crack cocaine exposure in preschool children: a preliminary report.
    Bender SL; Word CO; DiClemente RJ; Crittenden MR; Persaud NA; Ponton LE
    J Dev Behav Pediatr; 1995 Dec; 16(6):418-24; discussion 425-30. PubMed ID: 8746551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal cocaine exposure, child development, and the compromising effects of cumulative risk.
    Tronick EZ; Beeghly M
    Clin Perinatol; 1999 Mar; 26(1):151-71. PubMed ID: 10214547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine, anemia, and neurodevelopmental outcomes in children: a longitudinal study.
    Nelson S; Lerner E; Needlman R; Salvator A; Singer LT
    J Dev Behav Pediatr; 2004 Feb; 25(1):1-9. PubMed ID: 14767350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirty-six-month outcome of prenatal cocaine exposure for term or near-term infants: impact of early case management.
    Kilbride H; Castor C; Hoffman E; Fuger KL
    J Dev Behav Pediatr; 2000 Feb; 21(1):19-26. PubMed ID: 10706345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressive and receptive language functioning in preschool children with prenatal cocaine exposure.
    Morrow CE; Vogel AL; Anthony JC; Ofir AY; Dausa AT; Bandstra ES
    J Pediatr Psychol; 2004 Oct; 29(7):543-54. PubMed ID: 15347702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine/polydrug use in pregnancy: two-year follow-up.
    Chasnoff IJ; Griffith DR; Freier C; Murray J
    Pediatrics; 1992 Feb; 89(2):284-9. PubMed ID: 1370867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor delays in MDMA (ecstasy) exposed infants persist to 2 years.
    Singer LT; Moore DG; Min MO; Goodwin J; Turner JJ; Fulton S; Parrott AC
    Neurotoxicol Teratol; 2016; 54():22-8. PubMed ID: 26806601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth to age 7 growth of children prenatally exposed to drugs: a prospective cohort study.
    Covington CY; Nordstrom-Klee B; Ager J; Sokol R; Delaney-Black V
    Neurotoxicol Teratol; 2002; 24(4):489-96. PubMed ID: 12127894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal cocaine exposure: a comparison of 2-year-old children in parental and nonparental care.
    Brown JV; Bakeman R; Coles CD; Platzman KA; Lynch ME
    Child Dev; 2004; 75(4):1282-95. PubMed ID: 15260878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-exposed infants and developmental outcome: effects of a home intervention and ongoing maternal drug use.
    Schuler ME; Nair P; Kettinger L
    Arch Pediatr Adolesc Med; 2003 Feb; 157(2):133-8. PubMed ID: 12580681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of fetal cocaine exposure on neonatal auditory information processing.
    Potter SM; Zelazo PR; Stack DM; Papageorgiou AN
    Pediatrics; 2000 Mar; 105(3):E40. PubMed ID: 10699142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls.
    Cardonick EH; Gringlas MB; Hunter K; Greenspan J
    Am J Obstet Gynecol; 2015 May; 212(5):658.e1-8. PubMed ID: 25434835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome.
    Jacobson SW; Chiodo LM; Sokol RJ; Jacobson JL
    Pediatrics; 2002 May; 109(5):815-25. PubMed ID: 11986441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome from a prospective, longitudinal study of prenatal cocaine use: preschool development at 3 years of age.
    Behnke M; Eyler FD; Warner TD; Garvan CW; Hou W; Wobie K
    J Pediatr Psychol; 2006; 31(1):41-9. PubMed ID: 15827349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood.
    Serino Ma D; Peterson Md BS; Rosen Md TS
    J Dual Diagn; 2018; 14(3):158-170. PubMed ID: 29694295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine-exposed children: follow-up through 30 months.
    Hurt H; Brodsky NL; Betancourt L; Braitman LE; Malmud E; Giannetta J
    J Dev Behav Pediatr; 1995 Feb; 16(1):29-35. PubMed ID: 7730454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological correlates of fetal cocaine exposure: transient hypertonia of infancy and early childhood.
    Chiriboga CA; Vibbert M; Malouf R; Suarez MS; Abrams EJ; Heagarty MC; Brust JC; Hauser WA
    Pediatrics; 1995 Dec; 96(6):1070-7. PubMed ID: 7491223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.